J Chem Inf Model - Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.


{ compound(1573) activ(1297) structur(1058) }
{ model(2656) set(1616) predict(1553) }
{ method(1219) similar(1157) match(930) }
{ method(984) reconstruct(947) comput(926) }
{ problem(2511) optim(1539) algorithm(950) }
{ use(1733) differ(960) four(931) }
{ case(1353) use(1143) diagnosi(1136) }
{ gene(2352) biolog(1181) express(1162) }
{ measur(2081) correl(1212) valu(896) }
{ general(901) number(790) one(736) }
{ system(1976) rule(880) can(841) }
{ data(1714) softwar(1251) tool(1186) }
{ model(2220) cell(1177) simul(1124) }
{ use(2086) technolog(871) perceiv(783) }
{ model(3404) distribut(989) bayesian(671) }
{ imag(1947) propos(1133) code(1026) }
{ imag(1057) registr(996) error(939) }
{ error(1145) method(1030) estim(1020) }
{ data(3963) clinic(1234) research(1004) }
{ studi(1410) differ(1259) use(1210) }
{ survey(1388) particip(1329) question(1065) }
{ inform(2794) health(2639) internet(1427) }
{ take(945) account(800) differ(722) }
{ learn(2355) train(1041) set(1003) }
{ concept(1167) ontolog(924) domain(897) }
{ control(1307) perform(991) simul(935) }
{ model(2341) predict(2261) use(1141) }
{ health(3367) inform(1360) care(1135) }
{ state(1844) use(1261) util(961) }
{ group(2977) signific(1463) compar(1072) }
{ intervent(3218) particip(2042) group(1664) }
{ analysi(2126) use(1163) compon(1037) }
{ drug(1928) target(777) effect(648) }
{ activ(1452) weight(1219) physic(1104) }
{ can(774) often(719) complex(702) }
{ data(1737) use(1416) pattern(1282) }
{ bind(1733) structur(1185) ligand(1036) }
{ sequenc(1873) structur(1644) protein(1328) }
{ featur(3375) classif(2383) classifi(1994) }
{ imag(2830) propos(1344) filter(1198) }
{ network(2748) neural(1063) input(814) }
{ imag(2675) segment(2577) method(1081) }
{ patient(2315) diseas(1263) diabet(1191) }
{ studi(2440) review(1878) systemat(933) }
{ motion(1329) object(1292) video(1091) }
{ assess(1506) score(1403) qualiti(1306) }
{ treatment(1704) effect(941) patient(846) }
{ surgeri(1148) surgic(1085) robot(1054) }
{ framework(1458) process(801) describ(734) }
{ chang(1828) time(1643) increas(1301) }
{ clinic(1479) use(1117) guidelin(835) }
{ algorithm(1844) comput(1787) effici(935) }
{ extract(1171) text(1153) clinic(932) }
{ method(1557) propos(1049) approach(1037) }
{ design(1359) user(1324) use(1319) }
{ care(1570) inform(1187) nurs(1089) }
{ search(2224) databas(1162) retriev(909) }
{ featur(1941) imag(1645) propos(1176) }
{ howev(809) still(633) remain(590) }
{ risk(3053) factor(974) diseas(938) }
{ perform(999) metric(946) measur(919) }
{ research(1085) discuss(1038) issu(1018) }
{ system(1050) medic(1026) inform(1018) }
{ import(1318) role(1303) understand(862) }
{ visual(1396) interact(850) tool(830) }
{ perform(1367) use(1326) method(1137) }
{ studi(1119) effect(1106) posit(819) }
{ blood(1257) pressur(1144) flow(957) }
{ spatial(1525) area(1432) region(1030) }
{ record(1888) medic(1808) patient(1693) }
{ model(3480) simul(1196) paramet(876) }
{ monitor(1329) mobil(1314) devic(1160) }
{ ehr(2073) health(1662) electron(1139) }
{ research(1218) medic(880) student(794) }
{ patient(2837) hospit(1953) medic(668) }
{ data(2317) use(1299) case(1017) }
{ age(1611) year(1155) adult(843) }
{ medic(1828) order(1363) alert(1069) }
{ signal(2180) analysi(812) frequenc(800) }
{ cost(1906) reduc(1198) effect(832) }
{ sampl(1606) size(1419) use(1276) }
{ data(3008) multipl(1320) sourc(1022) }
{ first(2504) two(1366) second(1323) }
{ activ(1138) subject(705) human(624) }
{ time(1939) patient(1703) rate(768) }
{ patient(1821) servic(1111) care(1106) }
{ can(981) present(881) function(850) }
{ health(1844) social(1437) communiti(874) }
{ structur(1116) can(940) graph(676) }
{ high(1669) rate(1365) level(1280) }
{ cancer(2502) breast(956) screen(824) }
{ use(976) code(926) identifi(902) }
{ result(1111) use(1088) new(759) }
{ implement(1333) system(1263) develop(1122) }
{ estim(2440) model(1874) function(577) }
{ decis(3086) make(1611) patient(1517) }
{ process(1125) use(805) approach(778) }
{ method(1969) cluster(1462) data(1082) }
{ method(2212) result(1239) propos(1039) }
{ detect(2391) sensit(1101) algorithm(908) }


Profile-QSAR is a novel 2D predictive model building method for kinases. This "meta-QSAR" method models the activity of each compound against a new kinase target as a linear combination of its predicted activities against a large panel of 92 previously studied kinases comprised from 115 assays. Profile-QSAR starts with a sparse incomplete kinase by compound (KxC) activity matrix, used to generate Bayesian QSAR models for the 92 "basis-set" kinases. These Bayesian QSARs generate a complete "synthetic" KxC activity matrix of predictions. These synthetic activities are used as "chemical descriptors" to train partial-least squares (PLS) models, from modest amounts of medium-throughput screening data, for predicting activity against new kinases. The Profile-QSAR predictions for the 92 kinases (115 assays) gave a median external R?(ext) = 0.59 on 25% held-out test sets. The method has proven accurate enough to predict pairwise kinase selectivities with a median correlation of R?(ext) = 0.61 for 958 kinase pairs with at least 600 common compounds. It has been further expanded by adding a "C(k)XC" cellular activity matrix to the KxC matrix to predict cellular activity for 42 kinase driven cellular assays with median R?(ext) = 0.58 for 24 target modulation assays and R?(ext) = 0.41 for 18 cell proliferation assays. The 2D Profile-QSAR, along with the 3D Surrogate AutoShim, are the foundations of an internally developed iterative medium-throughput screening (IMTS) methodology for virtual screening (VS) of compound archives as an alternative to experimental high-throughput screening (HTS). The method has been applied to 20 actual prospective kinase projects. Biological results have so far been obtained in eight of them. Q? values ranged from 0.3 to 0.7. Hit-rates at 10 uM for experimentally tested compounds varied from 25% to 80%, except in K5, which was a special case aimed specifically at finding "type II" binders, where none of the compounds were predicted to be active at 10 ?M. These overall results are particularly striking as chemical novelty was an important criterion in selecting compounds for testing. The method is completely automated. Predicted activities for nearly 4 million internal and commercial compounds across 115 kinase assays and 42 cellular assays are stored in the corporate database. Like computed physical properties, this predicted kinase activity profile can be computed and stored as each compound is registered.

Resumo Limpo

profileqsar novel d predict model build method kinas metaqsar method model activ compound new kinas target linear combin predict activ larg panel previous studi kinas compris assay profileqsar start spars incomplet kinas compound kxc activ matrix use generat bayesian qsar model basisset kinas bayesian qsar generat complet synthet kxc activ matrix predict synthet activ use chemic descriptor train partialleast squar pls model modest amount mediumthroughput screen data predict activ new kinas profileqsar predict kinas assay gave median extern rext heldout test set method proven accur enough predict pairwis kinas select median correl rext kinas pair least common compound expand ad ckxc cellular activ matrix kxc matrix predict cellular activ kinas driven cellular assay median rext target modul assay rext cell prolifer assay d profileqsar along d surrog autoshim foundat intern develop iter mediumthroughput screen imt methodolog virtual screen vs compound archiv altern experiment highthroughput screen hts method appli actual prospect kinas project biolog result far obtain eight q valu rang hitrat um experiment test compound vari except k special case aim specif find type ii binder none compound predict activ m overal result particular strike chemic novelti import criterion select compound test method complet autom predict activ near million intern commerci compound across kinas assay cellular assay store corpor databas like comput physic properti predict kinas activ profil can comput store compound regist

Resumos Similares

J Am Med Inform Assoc - Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. ( 0,893304969946149 )
J Chem Inf Model - A new protocol for predicting novel GSK-3? ATP competitive inhibitors. ( 0,882562143151037 )
J Chem Inf Model - Profile-QSAR and Surrogate AutoShim protein-family modeling of proteases. ( 0,870556602663654 )
J Chem Inf Model - Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery. ( 0,858523018388973 )
J Chem Inf Model - Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. ( 0,854818538491824 )
J Chem Inf Model - Construction and use of fragment-augmented molecular Hasse diagrams. ( 0,852783406541763 )
J Chem Inf Model - Design and synthesis of new antioxidants predicted by the model developed on a set of pulvinic acid derivatives. ( 0,851568385385872 )
J Chem Inf Model - QSAR classification model for antibacterial compounds and its use in virtual screening. ( 0,849209843954011 )
J Chem Inf Model - Automated building of organometallic complexes from 3D fragments. ( 0,840284830677934 )
J Chem Inf Model - Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods. ( 0,834545291871571 )
J Chem Inf Model - Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands. ( 0,829619176350434 )
J Chem Inf Model - Compound set enrichment: a novel approach to analysis of primary HTS data. ( 0,82440410207403 )
J Chem Inf Model - Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening. ( 0,823537871152239 )
J Chem Inf Model - Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification. ( 0,823529471069244 )
J Chem Inf Model - Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application. ( 0,822351039333451 )
J Chem Inf Model - Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screening. ( 0,816925996735847 )
J Chem Inf Model - Structural similarity based kriging for quantitative structure activity and property relationship modeling. ( 0,816918231804539 )
J Chem Inf Model - Synthesis, bioassay, and molecular field topology analysis of diverse vasodilatory heterocycles. ( 0,8140244512029 )
J Chem Inf Model - Structure based model for the prediction of phospholipidosis induction potential of small molecules. ( 0,813458767061686 )
J Chem Inf Model - Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase. ( 0,813009313520642 )
J Chem Inf Model - TIN-a combinatorial compound collection of synthetically feasible multicomponent synthesis products. ( 0,812299312946474 )
J Chem Inf Model - Maximum-score diversity selection for early drug discovery. ( 0,812205220660182 )
J Chem Inf Model - Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. ( 0,812140654765908 )
J Chem Inf Model - Similarity boosted quantitative structure-activity relationship--a systematic study of enhancing structural descriptors by molecular similarity. ( 0,809345013475876 )
J Chem Inf Model - Identification of novel liver X receptor activators by structure-based modeling. ( 0,803526265554388 )
J Chem Inf Model - Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. ( 0,801542312424502 )
J Chem Inf Model - Automated recycling of chemistry for virtual screening and library design. ( 0,799623856028269 )
J Chem Inf Model - Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. ( 0,79916702437282 )
J Chem Inf Model - In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics. ( 0,799045392879769 )
J Chem Inf Model - ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes. ( 0,797230152038417 )
J Chem Inf Model - Modeling drug-induced anorexia by molecular topology. ( 0,797164300697813 )
J Chem Inf Model - Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators. ( 0,796831531939823 )
J Chem Inf Model - Development of Ecom50 and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. ( 0,791604169397056 )
J Chem Inf Model - Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. ( 0,791047891522798 )
J Chem Inf Model - Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. ( 0,790002582781409 )
J Chem Inf Model - Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening. ( 0,789037729581954 )
J Chem Inf Model - Freely available conformer generation methods: how good are they? ( 0,78865693471214 )
J Chem Inf Model - Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. ( 0,78859803707912 )
J Chem Inf Model - Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. ( 0,786535378195754 )
J Chem Inf Model - Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. ( 0,785209432620529 )
J Chem Inf Model - From activity cliffs to activity ridges: informative data structures for SAR analysis. ( 0,784334073818603 )
J Chem Inf Model - Combining horizontal and vertical substructure relationships in scaffold hierarchies for activity prediction. ( 0,784147676726436 )
J Chem Inf Model - Introduction of target cliffs as a concept to identify and describe complex molecular selectivity patterns. ( 0,783564118897225 )
J Chem Inf Model - Compound optimization through data set-dependent chemical transformations. ( 0,782880698841396 )
J Chem Inf Model - Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces. ( 0,782667093959759 )
J Chem Inf Model - Noncontiguous atom matching structural similarity function. ( 0,781671777463609 )
J Chem Inf Model - Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. ( 0,781369589860446 )
J Chem Inf Model - Navigating high-dimensional activity landscapes: design and application of the ligand-target differentiation map. ( 0,780715980821752 )
Curr Comput Aided Drug Des - Development of Chemical Compound Libraries for In Silico Drug Screening. ( 0,779016222589304 )
J Chem Inf Model - Jointly handling potency and toxicity of antimicrobial peptidomimetics by simple rules from desirability theory and chemoinformatics. ( 0,778561774799516 )
J Chem Inf Model - G-protein coupled receptors virtual screening using genetic algorithm focused chemical space. ( 0,777562144050059 )
J Chem Inf Model - Novel method for pharmacophore analysis by examining the joint pharmacophore space. ( 0,77659529375051 )
J Chem Inf Model - Identification of multitarget activity ridges in high-dimensional bioactivity spaces. ( 0,776327226192275 )
J Chem Inf Model - Target-independent prediction of drug synergies using only drug lipophilicity. ( 0,776192649810828 )
J Chem Inf Model - A multivariate chemical similarity approach to search for drugs of potential environmental concern. ( 0,776048210065906 )
J Chem Inf Model - Prediction of new bioactive molecules using a Bayesian belief network. ( 0,774896580622138 )
J Chem Inf Model - Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. ( 0,773525336678658 )
J Chem Inf Model - Visualization and virtual screening of the chemical universe database GDB-17. ( 0,773215077281615 )
J Chem Inf Model - Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening. ( 0,77245246274238 )
J Chem Inf Model - Increasing the coverage of medicinal chemistry-relevant space in commercial fragments screening. ( 0,771795746758644 )
J Chem Inf Model - Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation. ( 0,771625764524464 )
J Chem Inf Model - Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining. ( 0,771394587319241 )
J Chem Inf Model - Scanning structure-activity relationships with structure-activity similarity and related maps: from consensus activity cliffs to selectivity switches. ( 0,771323762008411 )
J Chem Inf Model - Identification of a new class of FtsZ inhibitors by structure-based design and in vitro screening. ( 0,770587675563394 )
J Integr Bioinform - Database supported candidate search for metabolite identification. ( 0,770286850424332 )
J Chem Inf Model - Quantitative structure-activity relationship models of chemical transformations from matched pairs analyses. ( 0,769800857081718 )
J Chem Inf Model - Novel mycosin protease MycP1 inhibitors identified by virtual screening and 4D fingerprints. ( 0,769742206864658 )
J Chem Inf Model - Computational repositioning and experimental validation of approved drugs for HIF-prolyl hydroxylase inhibition. ( 0,768420599550035 )
J Chem Inf Model - Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data. ( 0,767912199793177 )
J Chem Inf Model - Characterizing the diversity and biological relevance of the MLPCN assay manifold and screening set. ( 0,766306503402731 )
J Chem Inf Model - Discovery of a7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13. ( 0,765998041172541 )
J Chem Inf Model - De novo design of drug-like molecules by a fragment-based molecular evolutionary approach. ( 0,765719850481989 )
J Chem Inf Model - Natural product-like virtual libraries: recursive atom-based enumeration. ( 0,765566054734577 )
J Chem Inf Model - Bioturbo similarity searching: combining chemical and biological similarity to discover structurally diverse bioactive molecules. ( 0,765144663773138 )
J Chem Inf Model - Capturing structure-activity relationships from chemogenomic spaces. ( 0,764134570124446 )
J Chem Inf Model - Systematic assessment of compound series with SAR transfer potential. ( 0,763654311268705 )
J Chem Inf Model - Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor. ( 0,763323960608756 )
J Chem Inf Model - Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. ( 0,761694821615765 )
J Chem Inf Model - Knowledge-based libraries for predicting the geometric preferences of druglike molecules. ( 0,761678491575901 )
J Chem Inf Model - Atom pair 2D-fingerprints perceive 3D-molecular shape and pharmacophores for very fast virtual screening of ZINC and GDB-17. ( 0,761421713114646 )
J Chem Inf Model - Multitarget structure-activity relationships characterized by activity-difference maps and consensus similarity measure. ( 0,761048314269549 )
J Chem Inf Model - BioSM: metabolomics tool for identifying endogenous mammalian biochemical structures in chemical structure space. ( 0,760806589931606 )
J Chem Inf Model - Identification of novel serotonin transporter compounds by virtual screening. ( 0,760492292246401 )
J Chem Inf Model - Neighborhood-based prediction of novel active compounds from SAR matrices. ( 0,759643705969544 )
J Chem Inf Model - Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations. ( 0,758617562581692 )
J Chem Inf Model - SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition. ( 0,758201633726181 )
J Chem Inf Model - QSAR modeling of imbalanced high-throughput screening data in PubChem. ( 0,757303264546794 )
J Chem Inf Model - How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. ( 0,756332425483846 )
J Chem Inf Model - Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules. ( 0,755909538728349 )
J Chem Inf Model - Discovery of chemical compound groups with common structures by a network analysis approach (affinity prediction method). ( 0,755187735265694 )
J Chem Inf Model - Prediction of individual compounds forming activity cliffs using emerging chemical patterns. ( 0,752815968707823 )
J Chem Inf Model - Design of a three-dimensional multitarget activity landscape. ( 0,752478583720164 )
J Chem Inf Model - In silico prediction of aqueous solubility using simple QSPR models: the importance of phenol and phenol-like moieties. ( 0,75245959847603 )
J Chem Inf Model - Searching for recursively defined generic chemical patterns in nonenumerated fragment spaces. ( 0,750386546713435 )
J Chem Inf Model - Automatic tailoring and transplanting: a practical method that makes virtual screening more useful. ( 0,749159666451073 )
Comput Biol Chem - The optimization of running time for a maximum common substructure-based algorithm and its application in drug design. ( 0,749134055749985 )
J Chem Inf Model - Classification of compounds with distinct or overlapping multi-target activities and diverse molecular mechanisms using emerging chemical patterns. ( 0,748236116816588 )
J Chem Inf Model - Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes. ( 0,746435277790014 )
J Chem Inf Model - Hit expansion approaches using multiple similarity methods and virtualized query structures. ( 0,745252361233433 )
J Chem Inf Model - Structure-based design and screen of novel inhibitors for class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae. ( 0,744933518298348 )